What is Pexidartinib: Uses, Dosage, Side Effects and More

Pexidartinib is a targeted cancer medication that helps shrink tumors in a rare condition called tenosynovial giant cell tumor (TGCT). This prescription drug works by blocking specific proteins that fuel tumor growth, offering hope for people with this challenging condition.

If you or someone you care about has been diagnosed with TGCT, you probably have many questions about this treatment option. Let's walk through everything you need to know about pexidartinib in a way that feels manageable and clear.

What is Pexidartinib?

Pexidartinib is a prescription medication specifically designed to treat tenosynovial giant cell tumor, a rare but benign tumor that grows in joints and tendons. The drug belongs to a class called kinase inhibitors, which means it targets specific enzymes that help tumors grow.

You might know this medication by its brand name, Turalio. It comes as oral capsules that you take by mouth, making treatment more convenient than many other cancer therapies.

The medication received approval from the FDA in 2019, making it the first and only targeted therapy available for this specific type of tumor. This represents a significant breakthrough for people living with TGCT who previously had limited treatment options.

What is Pexidartinib Used For?

Pexidartinib treats tenosynovial giant cell tumor when surgery isn't possible or wouldn't be effective. This rare condition causes painful, swollen masses in your joints, most commonly affecting knees, ankles, hips, and fingers.

Your doctor will typically consider this medication if your tumor is too large to remove surgically, located in a difficult spot, or if previous surgeries haven't been successful. The goal is to shrink the tumor and reduce your symptoms like pain, swelling, and limited movement.

This medication is specifically approved for adults with TGCT that causes severe symptoms or functional limitations. It's not used for other types of tumors or cancer, as it's been designed specifically for this rare condition.

How Does Pexidartinib Work?

Pexidartinib works by blocking proteins called CSF1R, KIT, and FLT3 that act like fuel for TGCT tumors. Think of these proteins as switches that tell the tumor cells to grow and multiply.

By turning off these switches, the medication helps slow down tumor growth and can even shrink existing tumors. This targeted approach means the drug focuses specifically on the mechanisms driving your particular type of tumor.

This is considered a moderately strong medication that requires careful monitoring. While it's effective for its intended purpose, it can affect your liver function, so your healthcare team will keep a close eye on your overall health throughout treatment.

How Should I Take Pexidartinib?

Take pexidartinib exactly as your doctor prescribes, typically 400 mg twice daily with food. Taking it with meals helps your body absorb the medication better and may reduce stomach upset.

Swallow the capsules whole with water - don't crush, chew, or open them. If you have trouble swallowing capsules, talk to your healthcare provider about strategies that might help.

Try to take your doses at the same times each day, spacing them about 12 hours apart. This helps maintain steady levels of the medication in your system for the best possible results.

Before starting treatment, eat a light meal or snack. Foods that are easy on your stomach work well - think toast, crackers, or soup. Avoid taking the medication on an empty stomach as this can increase the risk of nausea.

How Long Should I Take Pexidartinib For?

Most people take pexidartinib for several months to see meaningful tumor shrinkage, though the exact duration varies from person to person. Your doctor will monitor your progress through regular scans and blood tests.

Treatment typically continues as long as the medication is working and you're tolerating it well. Some people may take it for six months to a year, while others might need longer treatment periods.

Your healthcare team will regularly assess whether the benefits continue to outweigh any side effects you're experiencing. This ongoing evaluation helps ensure you're getting the most appropriate care for your specific situation.

What Are the Side Effects of Pexidartinib?

Like all medications, pexidartinib can cause side effects, though not everyone experiences them. Understanding what to expect can help you feel more prepared and know when to reach out to your healthcare team.

The most common side effects affect many people taking this medication, but they're usually manageable with proper support and monitoring:

• Fatigue and feeling tired more than usual
• Nausea and stomach discomfort
• Hair color changes, particularly lightening
• Swelling in your hands, feet, or face
• Diarrhea or changes in bowel movements
• Muscle and joint pain
• Changes in taste
• Headaches

These common side effects often improve as your body adjusts to the medication. Your healthcare team can suggest ways to manage them and make you more comfortable during treatment.

More serious side effects require immediate medical attention, though they're less common. These include signs of liver problems and other concerning symptoms:

• Yellowing of your skin or eyes
• Dark urine or pale stools
• Severe nausea or vomiting
• Unusual bleeding or bruising
• Severe fatigue or weakness
• Abdominal pain or swelling
• Difficulty breathing or chest pain

If you notice any of these serious symptoms, contact your healthcare provider immediately. Early detection and treatment of side effects can help prevent more serious complications.

Who Should Not Take Pexidartinib?

Pexidartinib isn't suitable for everyone, and certain health conditions or circumstances make this medication unsafe. Your doctor will carefully review your medical history before prescribing it.

People with existing liver problems should generally avoid this medication, as it can worsen liver function. Your healthcare provider will run blood tests to check your liver before starting treatment.

Pregnant or breastfeeding women should not take pexidartinib, as it can harm developing babies. If you're of childbearing age, you'll need to use effective birth control during treatment and for some time afterward.

Additional conditions that may prevent you from taking this medication include severe kidney disease, certain heart problems, or if you're taking medications that interact dangerously with pexidartinib.

Pexidartinib Brand Name

Pexidartinib is sold under the brand name Turalio. This is the only brand name available for this medication, as it's a relatively new drug with patent protection.

When you pick up your prescription, you'll see "Turalio" on the bottle label. The generic name "pexidartinib" might also appear, but both refer to the same medication.

Currently, no generic versions of pexidartinib are available. This means Turalio is the only option, which can make the medication quite expensive without proper insurance coverage.

Pexidartinib Alternatives

Currently, there are no direct alternatives to pexidartinib for treating tenosynovial giant cell tumor. This medication is the first and only targeted therapy approved specifically for this rare condition.

Before pexidartinib became available, treatment options were limited to surgery, radiation therapy, or watchful waiting. Surgery remains an option for some people, depending on the tumor's location and size.

If you can't take pexidartinib due to side effects or other health concerns, your doctor might suggest clinical trials investigating new treatments. These research studies can sometimes provide access to promising experimental therapies.

Is Pexidartinib Better Than Surgery?

Pexidartinib and surgery serve different purposes and aren't directly comparable treatments. Surgery aims to physically remove the tumor, while pexidartinib works to shrink it using targeted therapy.

Surgery is often the first choice when the tumor is small, easily accessible, and complete removal is possible. However, TGCT tumors can be difficult to remove entirely and may return after surgery.

Pexidartinib becomes the preferred option when surgery isn't feasible due to tumor size, location, or previous failed surgical attempts. The medication can be particularly valuable for tumors that wrap around important structures like blood vessels or nerves.

Your healthcare team will help determine which approach makes most sense for your specific situation, considering factors like tumor characteristics, your overall health, and treatment goals.